Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Takako Nozaki"'
Autor:
H. Murata, Tsukasa Ashihara, Yasusuke Hirasawa, Shin Hashiguchi, Hideyuki Takeshita, Takako Nozaki, Katsuyuki Kusuzaki, K. Emoto, S. Sugimoto
Publikováno v:
Osteoarthritis and Cartilage. 9(7):664-670
Objective Since most chondrocytes in articular cartilage are in the resting phase (G0) of the cell cycle, it has been difficult to investigate their cell kinetics using 3H-thymidine autoradiography, or immunohistochemistry. In the present study, DNA
Photodynamic Inactivation with Acridine Orange on a Multidrug‐resistant Mouse Osteosarcoma Cell Line
Autor:
Shin Hashiguchi, Tsukasa Ashihara, Hiroaki Murata, Ginjirou Minami, Takako Nozaki, Hideyuki Takeshita, Katsuyuki Kusuzaki, Yasusuke Hirasawa
Publikováno v:
Japanese Journal of Cancer Research : Gann
Overcoming multidrug resistance (MDR) is an urgent issue to improve the prognosis of osteosarcoma patients. In this study, we undertook to clarify the effect of photodynamic therapy (PDT) with acridine orange (AO) on the MDR mouse osteosarcoma (MOS /
Autor:
Takako Nozaki, Kazuei Igarashi, Yoshimi Kakinuma, Takaharu Maruyama, Ken Nishimura, Anthony J. Michael
Publikováno v:
Biochemical and Biophysical Research Communications. 228:452-458
We have isolated a new gene (PTK2) which restores spermine uptake of a polyamine uptake-deficient mutant of Saccharomyces cerevisiae (Kakinuma, Y., Maruyama, T., Nozaki, T., Wada, Y., Oshumi, Y., and Igarashi, K., 1995, Biochem, Biophys. Res. Commun.
Autor:
Hideyuki Takeshita, Yasusuke Hirasawa, Takako Nozaki, H. Murata, Katsuyuki Kusuzaki, Shin Hashiguchi, Tsukasa Ashihara, K. Emoto
Publikováno v:
Osteoarthritis and cartilage. 9(2)
Objective Although it is well known that binuclear cells commonly appear among the chondrocytes of normal cartilages as well as among neoplastic chondrocytes of chondrosarcomas, the mechanism of binucleation is still unclear. Therefore, this study wa
Autor:
Hideyuki Takeshita, Takako Nozaki, Shinichirou Nakamura, Hiroaki Murata, Katsuyuki Kusuzaki, Shin Hashiguchi, Yasusuke Hirasawa
Publikováno v:
Oncology Reports.
We examined the survival prognosis of patients with osteosarcoma after orally administering the active form of vitamin D3, 1alpha (OH) D3 (alphaD3). The 29 patients, ranging in age from 9 to 58 years (mean, 19 years), with osteosarcoma were treated i